Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-MY-101480-3   |   PDF   |   Print   |  
published: 14 Dec 2010 last updated: 17 May 2022
General Information
RISK ASSESSMENT REPORT OF THE GENETIC MODIFICATION ADVISORY COMMITTEE (GMAC) FOR AN APPLICATION TO CONDUCT A LIMITED MARK-RELEASE-RECAPTURE OF Aedes aegypti (L.) WILD TYPE AND OX513A STRAINS
EN
07 May 2010
Risk assessment details
  • Dominant lethal Aedes aegypti mosquito
    | Oxitec Limited | Changes in physiology and/or production (Reproduction), Changes in quality and/or metabolite content (Pigmentation / Coloration), Selectable marker genes and reporter genes
Methodology and points to consider
Please refer to Risk Assessment Report
EN
Please refer to Risk Assessment Report
EN
Please refer to Risk Assessment Report
EN
Please refer to Risk Assessment Report
EN
Recommendation is that the field trial is approved with terms and conditions as it does not endanger biological diversity or human, animal and plant health. Terms and conditions are imposed as risk management strategies. 
EN
EN
EN
EN
Information sharing with other databases
No
Additional information
EN
Loading...